Urenco Annual Report 2022

7. Investments in subsidiaries and associate Share in subsidiary and associated undertakings €m Cost as at 1 January 2022 and 31 December 2022 527.8 Impairment as at 1 January 2022 and 31 December 2022 (232.9) Carrying amount as at 1 January 2022 and 31 December 2022 294.9 Details of the Company’s subsidiaries and associate at 31 December 2022 are as follows: Nature of business Registered office Note Proportion of ownership interest and voting power held % Name of subsidiary Urenco Enrichment Company Limited Holding / central services (1) 100 Urenco UK Limited Enrichment services (2) (i) 100 Urenco ChemPlants Limited Deconversion (2) 100 Urenco Deutschland GmbH Enrichment services (3) (i) 100 Urenco Nederland BV Enrichment services (4) (i) 100 Urenco Deelnemingen BV Holding (4) (i) 100 Urenco Finance NV Financing (4) 100 Urenco USA Holdings Limited Holding (1) 100 Urenco USA Inc. Holding (6) (i) 100 Urenco Inc. Sales / marketing (5) (i) 100 Urenco Finance UK Limited Dormant (1) (i) 100 Urenco Finance US LLC Dormant (6) (i) 100 Louisiana Energy Services, LLC Enrichment services (6) (i) 100 Urenco Nuclear Stewardship Limited Uranium handling services (2) 100 Urenco USA Energy Services LLC Support services (6) (i) 100 U-Battery Limited Holding (1) 100 U-Battery Developments Limited New technology (1) (i) 100 U-Battery Canada Limited New technology (8) (i) 100 Urenco UK Pension Trustee Company Limited Dormant (2) (i) 100 Urenco Technology and Development GmbH Dormant (3) 100 National Enrichment Facility Series 2004 LLC Financing (6) (i) 100 Urenco Funding Limited Financing (1) 100 Urenco Stable Isotopes North America LLC Sales / marketing (6) (i) 100 Nuclear Decommissioning Trust Agreement Decommissioning Fund (9) (i) 100(iii) Name of associate Enrichment Technology Company Limited Manufacturing (7) (ii) 50 Address of registered office of subsidiary or associated companies: (1) Urenco Court, Sefton Park, Bells Hill, Stoke Poges, Buckinghamshire, SL2 4JS, England (2) Capenhurst Works, Capenhurst, Chester, Cheshire, CH1 6ER, England (3) Rontgenstrasse 4, 48599 Gronau, Germany (4) Drienemansweg 1, 7601 PZ Almelo, The Netherlands (5) 1560 Wilson Boulevard, Suite 300, Arlington, Virginia, 22209-2463, USA (6) 1209 Orange Street, Wilmington, New Castle County, Delaware, 19801, USA (7) Unit 6, South Capenhurst Technology Park, Capenhurst, Chester, CH1 6EH, England (8) 250 Howe Street, Suite 1400, Vancouver, British Columbia, V6C 3S7, Canada (9) The Huntington National Bank, 150 Ottawa Ave, Grand Rapids, MI, 49505, USA Detail of direct and indirect holdings: (i) Denotes companies / partnership whose shares are indirectly held by Urenco Limited (ii) 21.7% is held directly by Urenco Limited, with the remaining 28.3% held by Urenco Deutschland GmbH (iii) The Company controls this structured entity by means of contractual arrangements. Financial statements Notes to the Company Financial Statements continued For the year ended 31 December 2022 173 Urenco Annual report and accounts 2022 Financial statements 03